Table 3.

Sociodemographic and study details of qualitative and quantitative samples

	Participants providing qualitative data (n = 27)			Participants providing quantitative data (n = 125)
	Prescribers	Supporters	Prescriber-supporters	Prescribers	Supporters	Prescriber-supporters
n	13	11	3	62	58	5
Gender	5 female (38%)	10 female (91%)	3 female (100%)	22 female (35%)	55 female (95%)	3 female (60%)
Mean n of patients in intervention group at each Practice (range)	5 (2–10)	5 (2–8)	7 (2–10)	4.3 (− 1–12)	4.4 (1–12)	6.2 (2–10)
Mean n of weeks from randomisation of first participant to time of interview (range)	29 weeks (17–54)	27 weeks (20–43)	20 weeks (16–24)	N/A
Mean duration of interview (range)	26:14 (14–37 min)	29:02 (11–62 min)	43:19 (37–53 min)	N/A
Mean n of recommendations for medication escalation received by prescriber at point of interview (range)	3 (0–7)	N/A	3 (1–4)	N/A